Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab

Published: 3 May 2022
Abstract Views: 1895
PDF: 455
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Not available

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Maranini B, Ciancio G, Cultrera R, Govoni M. Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis. Reumatismo. 2021; 73: 1445. DOI: https://doi.org/10.4081/reumatismo.2021.1445
Algaadi SA. Herpes zoster and COVID-19 infection: a coincidence or a causal relationship? Infection. 2021 Nov 22: 1-5. DOI: https://doi.org/10.1007/s15010-021-01714-6
Ting SW, Ting SY, Lin YS, et al. Risk of herpes zoster in psoriasis patients receiving systemic therapies: a nationwide population-based cohort study. Sci Rep. 2021; 11: 11824. DOI: https://doi.org/10.1038/s41598-021-91356-3
Chiu YM, Tang CH, Hung ST, et al. A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study. Scand J Rheumatol. 2017; 46: 236-40. DOI: https://doi.org/10.1080/03009742.2016.1202318
Ma C, Walters B, Fedorak RN. Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn’s disease. World J Gastroenterol. 2013; 19: 3347-51. DOI: https://doi.org/10.3748/wjg.v19.i21.3347
Li J, Zhang Z, Wu X, et al. Risk of adverse events after anti-TNF treatment for inflammatory rheumatological disease. A meta-analysis. Front Pharmacol. 2021; 12: 746396. DOI: https://doi.org/10.3389/fphar.2021.746396

How to Cite

Finsterer, J. (2022). Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab. Reumatismo, 74(1). https://doi.org/10.4081/reumatismo.2022.1474